Q98407173

Summary

Q98407173 is a report^[1].

Key Facts

• Q98407173's instance of is recorded as report^[2].
• Q98407173's part of the series is recorded as reports of the 2017/18 legislative session of the Riksdag^[3].
• Q98407173's language of work or name is recorded as Swedish^[4].
• Q98407173 was released on +2018-05-25T00:00:00Z^[5].
• Q98407173's significant event is recorded as debate^[6].
• Q98407173's main subject is medication^[7].
• Q98407173's work available at URL is recorded as http://data.riksdagen.se/dokument/H501UbU26^[8].
• Q98407173's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/H501UbU26^[9].
• Q98407173's work available at URL is recorded as http://data.riksdagen.se/fil/546DFE64-6F2F-4BB7-8339-3E201CF2F039^[10].
• Q98407173's applies to jurisdiction is recorded as Sweden^[11].
• Q98407173's legal citation of this text is recorded as bet. 2017/18:UbU26^[12].
• Q98407173's title is recorded as Kompletterande bestämmelser om etisk granskning till EU-förordningen om kliniska läkemedelsprövningar^[13].
• Q98407173's has immediate cause is recorded as Q97756066^[14].
• Q98407173's has immediate cause is recorded as Q98120601^[15].
• Q98407173's maintained by WikiProject is recorded as Project Riksdagen's documents^[16].
• Q98407173's copyright status is recorded as public domain^[17].
• Q98407173's legislative committee is recorded as Committee on Education^[18].

Body

Definition and Type

Q98407173's instance of is recorded as report^[2].